PRDMX
Price
$49.32
Change
+$0.21 (+0.43%)
Updated
Jun 22 closing price
Net Assets
4.78B
VMGMX
Price
$132.08
Change
+$0.31 (+0.24%)
Updated
Jun 22 closing price
Net Assets
33.76B
Interact to see
Advertisement

PRDMX vs VMGMX

PRDMX vs VMGMX Comparison Chart in %
View a ticker or compare two or three
VS
PRDMX vs. VMGMX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRDMX is a Hold and VMGMX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMGMX has more cash in the bank: 33.8B vs. PRDMX (4.78B). VMGMX pays higher dividends than PRDMX: VMGMX (0.62) vs PRDMX (0.00). PRDMX was incepted earlier than VMGMX: PRDMX (22 years) vs VMGMX (15 years). PRDMX (0.84) is less costly to investors than VMGMX (0.07). PRDMX is a more actively managed with annual turnover of: 51.30 vs. VMGMX (17.00). PRDMX has a lower initial minimum investment than VMGMX: PRDMX (2500) vs VMGMX (3000). VMGMX annual gain was more profitable for investors over the last year : 11.76 vs. PRDMX (0.72). VMGMX return over 5 years is better than : 31.10 vs. PRDMX (-1.03).
PRDMXVMGMXPRDMX / VMGMX
Total Expense Ratio0.840.071,200%
Annual Report Gross Expense Ratio0.840.071,200%
Fund Existence22 years15 years-
Gain YTD5.0719.95251%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets4.78B33.8B14%
Annual Yield % from dividends0.000.62-
Returns for 1 year0.7211.766%
Returns for 3 years25.7655.5346%
Returns for 5 years-1.0331.10-3%
Returns for 10 years116.67213.1355%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TEMUX22.59N/A
N/A
Morgan Stanley Pathway Em Mkts Eq
MRICX26.84N/A
N/A
MFS Research International C
ICSSX16.85N/A
N/A
VY® Columbia Small Cp Val & InflectionS
ALVDX11.09N/A
N/A
American Century Focused Lg Cap Val R6
BRUMX18.35N/A
N/A
MFS Blended Research Value Equity R4